Efficacy and Safety of Pantoprazole versus Ranitidine in the Treatment of Patients with Symptomatic Gastroesophageal Reflux Disease

Publisher： Karger

E-ISSN： 1421-9867|70|1|61-69

ISSN： 0012-2823

Source： Digestion, Vol.70, Iss.1, 2004-09, pp. : 61-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of Rabeprazole in the Treatment of Symptomatic Gastroesophageal Reflux Disease

By Kahrilas Peter   Miner Philip   Johanson John   Mao Lian   Jokubaitis Leonard   Sloan Sheldon  

Digestive Diseases and Sciences, Vol. 50, Iss. 11, 2005-11 ,pp. : 2009-2018

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of Pantoprazole 20 mg to Ranitidine 150 mg b.i.d. in the Treatment of Mild Gastroesophageal Reflux Disease

By  

Digestion, Vol. 63, Iss. 3, 2001-05 ,pp. : 163-170

Karger

Access to resources Recommend Favorite

Health-Related Quality of Life Outcomes of Omeprazole versus Ranitidine in Poorly Responsive Symptomatic Gastroesophageal Reflux Disease

By  

Digestive Diseases, Vol. 16, Iss. 5, 1999-01 ,pp. : 284-291

Karger

Access to resources Recommend Favorite

Intravenous Pantoprazole as Initial Treatment in Patients With Gastroesophageal Reflux Disease and a History of Erosive Esophagitis: A Randomized Clinical Trial

By Pratha Vijaya   Hogan Daniel   Lynn Richard   Field Brian   Metz David  

Digestive Diseases and Sciences, Vol. 51, Iss. 9, 2006-09 ,pp. : 1595-1601

Springer Publishing Company

Access to resources Recommend Favorite

Empirical Therapy for Symptomatic Gastroesophageal Reflux Disease in Primary Care: Determinants of Efficacy

By  

Digestion, Vol. 76, Iss. 3-4, 2007-12 ,pp. : 207-214

Karger

Access to resources Recommend Favorite